GGrantIndex
← Search

Regional Oncology Research Center (American Eurasian Cancer Alliance Supplement)

$480,981P30FY2023CANIH

Johns Hopkins University, Baltimore MD

Investigators

Linked publications, trials & patents

Trial NCT02989636Trial NCT02516670Trial NCT02491411Trial NCT02489357Trial NCT02029950Trial NCT01935947Trial NCT01870596Trial NCT01783171Trial NCT01757639Trial NCT01578109Trial NCT01349972Trial NCT01349959Trial NCT01330173Trial NCT01264432Trial NCT01207726Trial NCT01207687Trial NCT01139970Trial NCT01132573Trial NCT01061749Trial NCT00971737Trial NCT00963807Trial NCT00899951Trial NCT00899548Trial NCT00898482Trial NCT00897338Trial NCT00897273Trial NCT00847171Trial NCT00795002Trial NCT00727441Trial NCT00673569Trial NCT00670917Trial NCT00660348Trial NCT00641303Trial NCT00641147Trial NCT00631137Trial NCT00616967Trial NCT00602771Trial NCT00588991Trial NCT00566098Trial NCT00524017Trial NCT00499733Trial NCT00499486Trial NCT00493025Trial NCT00492921Trial NCT00489281Trial NCT00478062Trial NCT00478010Trial NCT00471653Trial NCT00470093Trial NCT00469820Trial NCT00445484Trial NCT00433472Trial NCT00425477Trial NCT00407966Trial NCT00401024Trial NCT00389610Trial NCT00387465Trial NCT00381550Trial NCT00373191Trial NCT00369681Trial NCT00368914Trial NCT00363649Trial NCT00361296Trial NCT00356928Trial NCT00354640Trial NCT00343447Trial NCT00336063Trial NCT00334542Trial NCT00324870Trial NCT00313560Trial NCT00311623Trial NCT00305760Trial NCT00303927Trial NCT00293410Trial NCT00293397Trial NCT00293280Trial NCT00290732Trial NCT00287989Trial NCT00287872Trial NCT00281970Trial NCT00281866Trial NCT00278200Trial NCT00278161Trial NCT00278109Trial NCT00276744Trial NCT00276601Trial NCT00276588Trial NCT00274768Trial NCT00265915Trial NCT00265837Trial NCT00262834Trial NCT00258206Trial NCT00258180Trial NCT00255775Trial NCT00255710Trial NCT00245115Trial NCT00244959Trial NCT00242996Trial NCT00238368Trial NCT00238277

Abstract

Project Summary/Abstract The American Eurasian Cancer Alliance (AECA) was formed in 2001, originally called American Russian Cancer Alliance (ARCA), representing a unique partnership of scientists and clinicians from Russian Federation and the United States. Based on the successes of ARCA and growing interest from Eastern European and Central Asian countries, the scope and depth of the alliance expanded to the Eurasian region encompassing research, research training, research to policy, and health diplomacy activities. The program was re-branded under the American Eurasian Cancer Alliance (AECA) in 2014 to represent the wider range of national participation, which encompasses the following regions: Russian Federation, Central Asia (Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan), Central Europe (Ukraine, Moldova, Belarus), Baltics (Lithuania, Latvia, Estonia), and Caucasus (Armenia, Georgia, Azerbaijan). The Alliance aims to pool intellectual and scientific resources to further research and discovery in cancer prevention and treatment strategies. AECA’s programs focus on three main areas: 1. Strengthening Global Cancer Research 2. Promoting Research Training and Education 3. Translating Research into Policy and Programs AECA has formed partnerships with several countries in Eurasia which were formalized through Memoranda of Understanding between Ministries of Health for cooperation in cancer research, prevention, and control. Through continued engagement with high-level stakeholders, AECA facilitates allocation of resources by Eurasian governments and cancer research institutes for the mutual benefit of U.S. and local populations. This engagement results in reduced financial burden to NCI-Designated Cancer Centers, and other U.S.-based institutes to establish and implement their research programs. During the COVID pandemic, AECA has continued its worked uninterrupted, albeit through virtual channels, by continuing to facilitate research, conducting education and public health initiatives. AECA works with NCI personnel in this effort.

View original record on NIH RePORTER →